Member Info for ontarget

I suspect Juvlife are focusing on their pharmaceutical pipeline as well - their neutraceutical pipeline page/info disappeared from their website some time ago

https://juvlabs.com/pages/pipeline-highlights

A very old article. Greg Bailey left as CEO last year.

Market cap wise, it's 11x higher. Not checked the debt.

Scientific news "Very shortly" according to yesterday's presentation.

And very obvious from the comments and Q&A answers that it will not be negative.

Presentatio / Q&A is up on Youtube now: https://www.youtube.com/watch?v=F5SG0oSDVbk

From last night: https://www.youtube.com/watch?v=kUmbc9c2pM8

It's in the RNS

"In the Quarter, the company received notification from the Tanzanian Revenue Authority that VAT refunds of US$6.7 m for the period up to March 2023 had been audited with payment to be expected in Q3."

Https://www.youtube.com/watch?v=rei_F_LW5Ik

Dollar index plummeting - has the tide finally turned?

Q2 results due around 20/7 should help.

Yes from the 1/6 RNS this is the expected news:

"FY 2023 production guidance for Singida to follow in June 2023 including 5-year forecast"

Usual nonsense from our resident trader troll.

Actually it was a rebranding at some point by Odey (can't see a date on this article):

Https://portfolio-adviser.com/revealed-odey-am-quietly-rebrands-1-3bn-of-funds-as-crispin-odeys-next-trial-date-looms/

Looks like they are a subsidiary of Odey, just Eric just being more specific than normal about who owns/owned the shares.

You can read the slides on Shanta website:

Https://shantagold.com/_resources/Proactive%20Investors%20Presentation%2021%20June%202023.pdf

The other reason is every trade is by definition both a buy and a sell.

£5m in the bank Kingalf, before any milestone payments.

Spend was unusually high last year due to the Pk/Pd trial costs. Will be lower this year - the next two trials are paid for by Stalicla (ASD) and investigator sponsor (Glioma).

Both trials btw are due to start in around 6 months time as per the latest RNS.

You don't have to be a CEO or even a director to buy SHG shares deepjoy.

Added 250k at 10p.

HUM - one to avoid agree, massive debts with ever-increasing interest rates.

Nominal is 0.01p so still plenty of room for Bell to dilute into oblivion.